論文

国際誌
2016年1月1日

GONAD: A Novel CRISPR/Cas9 Genome Editing Method that Does Not Require Ex Vivo Handling of Embryos.

Current protocols in human genetics
  • Channabasavaiah B Gurumurthy
  • ,
  • Gou Takahashi
  • ,
  • Kenta Wada
  • ,
  • Hiromi Miura
  • ,
  • Masahiro Sato
  • ,
  • Masato Ohtsuka

88
開始ページ
15.8.1-15.8.12
終了ページ
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1002/0471142905.hg1508s88

Transgenic technologies used for creating a desired genomic change in animals involve three critical steps: isolation of fertilized eggs, microinjection of transgenic DNA into them and their subsequent transfer to recipient females. These ex vivo steps have been widely used for over 3 decades and they were also readily adapted for the latest genome editing technologies such as ZFNs, TALENs, and CRISPR/Cas9 systems. We recently developed a method called GONAD (Genome editing via Oviductal Nucleic Acids Delivery) that does not require all the three critical steps of transgenesis and therefore relieves the bottlenecks of widely used animal transgenic technologies. Here we provide protocols for the GONAD system.

リンク情報
DOI
https://doi.org/10.1002/0471142905.hg1508s88
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/26724720
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733652
ID情報
  • DOI : 10.1002/0471142905.hg1508s88
  • PubMed ID : 26724720
  • PubMed Central 記事ID : PMC4733652

エクスポート
BibTeX RIS